Within tumors, higher TGF-β1 levels were significantly associated with higher tumor stage and grade and correlated with cancer-specific death (Kim et al., 2001; Yang et al., 2018; Stojnev et al., 2019; Zou et al., 2019). The gene discussed is TGFB1; the disease is cancer.